Levamisole

合成経路と反応条件

レバミゾールは、いくつかの方法で合成できます。 一般的な方法の1つは、2-イミノ-1,3-チアゾリジンと2-フェニル-2-ヒドロキシエチルアミンの反応によるものです 。 この反応は、イミダゾチアゾール環構造を形成する環化反応によって続きます。 反応条件には、通常、塩化チオニルと無水酢酸を使用することが含まれます .

工業的製造方法

レバミゾール塩酸塩の工業的製造には、L-テトラミゾールをアセトンに溶解し、亜セレン酸ナトリウムを加える方法が用いられます 。 次に、この混合物を活性炭を使用して脱色し、ろ過します。 pH値が3〜5になるまで、撹拌しながら乾燥した塩化水素ガスを導入します。 次に、反応混合物を分離して精製し、最終生成物を得ます .

反応の種類

レバミゾールは、酸化、還元、置換などの様々な化学反応を起こします .

一般的な試薬と条件

酸化： レバミゾールは、酸性条件下で過マンガン酸カリウムや過酸化水素などの試薬を使用して酸化できます.

還元： 還元反応は、水素化ホウ素ナトリウムや水素化リチウムアルミニウムなどの還元剤を使用して行うことができます.

置換： 置換反応は、通常、塩基性条件下でハロゲン化物やアミンなどの求核剤を伴います.

主要な生成物

これらの反応から形成される主要な生成物は、使用した特定の試薬と条件によって異なります。 例えば、レバミゾールの酸化は、スルホキシドまたはスルホンを形成することができます .

科学研究への応用

レバミゾールは、幅広い科学研究への応用があります。

化学： 不斉合成におけるキラル補助剤として使用されます.

生物学： T細胞の活性化と増殖など、免疫系への影響が研究されています.

医学： 結腸癌やその他の悪性腫瘍の治療における補助療法として使用されます。

産業： 家畜の寄生虫感染症を治療するための獣医学で使用されています.

Medical Applications

1. Anthelmintic Use
Levamisole's primary application is as an anthelmintic drug, effective against intestinal roundworms (ascariasis) and hookworms (ancylostomiasis). It functions by acting as a nicotinic acetylcholine receptor agonist, leading to paralysis of the worms and subsequent expulsion from the host's body .

2. Immunomodulation
this compound has been recognized for its immunomodulatory effects, particularly in conditions characterized by immune dysfunction. It has been studied in the context of:

• Rheumatoid Arthritis : this compound was evaluated for its ability to improve immune responses in patients with rheumatoid arthritis, showing some efficacy in restoring T-cell function .
• Nephrotic Syndrome : Clinical trials have indicated that this compound may benefit children with nephrotic syndrome by enhancing immune response and reducing proteinuria .

3. Cancer Therapy
this compound has been investigated as an adjunct treatment in various cancers:

• Colon Cancer : It gained attention for its use in combination with fluorouracil (5-FU) as adjuvant therapy for stage III colon cancer. The combination has shown improved outcomes compared to 5-FU alone .
• Melanoma and Other Cancers : While trials in advanced breast cancer and lung cancer have yielded inconclusive results, some studies suggest potential benefits when used as part of a combination therapy .

Veterinary Applications

This compound is extensively used in veterinary medicine to treat parasitic infections in livestock and pets. Its applications include:

• Cattle and Sheep : It is commonly used to control gastrointestinal roundworms, lungworms, and other parasites .
• Aquaculture : this compound is employed by aquarists to treat specific parasitic infections in fish, such as Camallanus roundworm infestations .

Laboratory Applications

In research settings, this compound serves several functions:

• Enzyme Inhibition : It acts as a reversible inhibitor of alkaline phosphatase, which is useful in various biochemical assays such as Western blotting and in situ hybridization .
• Nematode Studies : this compound is utilized to immobilize nematodes like Caenorhabditis elegans for imaging or dissection purposes .

Table 1: Summary of this compound Applications

Case Studies

Case Study 1: this compound in Colon Cancer Treatment
A randomized clinical trial involving patients with Dukes' C stage C colon carcinoma demonstrated that the addition of this compound to standard chemotherapy (5-FU) improved disease-free survival rates compared to 5-FU alone. This study highlighted this compound's role as an effective adjuvant therapy despite its withdrawal from the market due to safety concerns related to impurities .

Case Study 2: Immunomodulatory Effects in Nephrotic Syndrome
In a cohort study of children with nephrotic syndrome, patients treated with this compound showed significant reductions in proteinuria and improvements in renal function markers. This study supports the hypothesis that this compound can modulate immune responses effectively in pediatric populations .

レバミゾールは、ニコチン性アセチルコリン受容体の作動薬として作用し、寄生虫の筋肉の持続的な刺激を引き起こし、麻痺と排出につながります 。 免疫調節作用において、レバミゾールは抗体の産生を促進し、T細胞応答を強化し、単球とマクロファージの機能を増強します 。 また、好中球の移動性、接着性、走化性を高めます .

Anthelmintic Agents

Nicotine and Ganglionic Stimulants

Levamisole’s mechanism of action and toxicity closely resemble nicotine. Both compounds induce vasopressor effects, muscle tremors, and hyperesthesia by stimulating nAChRs. However, this compound’s vasopressor activity is selectively blocked by α-adrenergic antagonists (e.g., phentolamine), unlike nicotine, which is inhibited by ganglionic blockers like hexamethonium .

Benzimidazoles (Albendazole, Mebendazole)

This compound is often combined with benzimidazoles for synergistic anthelmintic effects. In trichuriasis, albendazole + this compound achieves a 95.8% cure rate compared to 46.2% with albendazole alone, likely due to this compound’s neuromuscular action enhancing benzimidazole’s tubulin-disrupting effects .

Immunomodulators and Chemotherapeutics

Steroid-Sparing Agents (Gold, D-Penicillamine)

In idiopathic nephrotic syndrome, this compound demonstrates comparable efficacy to gold and D-penicillamine but with a superior safety profile. It reduces relapse rates by 50–70% without nephrotoxicity or hepatotoxicity, unlike gold, which carries risks of proteinuria and cytopenia .

Suramin and Angiogenesis Inhibitors

N-alkylated this compound derivatives, such as N-methylthis compound, exhibit antiangiogenic activity distinct from suramin. While suramin inhibits vascular network formation via small cord morphology, N-methylthis compound induces cluster formation at lower concentrations (30 µM), suggesting a unique mechanism .

Alkaline Phosphatase Inhibitors

This compound and the experimental compound R8231 differentially inhibit alkaline phosphatases (ALPs). Mammalian bone ALP is 10–100× more sensitive to this compound than avian ALP, whereas R8231 shows potent inhibition across species. This selectivity makes R8231 a superior probe for studying ALP’s role in bone metabolism .

Structural and Functional Derivatives

Tetramisole

Tetramisole, the racemic mixture of this compound, has weaker anthelmintic activity. The (S)-enantiomer (this compound) is 10× more potent than the (R)-form, highlighting the importance of chirality in efficacy .

N-Alkylated Derivatives

N-methylthis compound and p-bromothis compound disrupt angiogenesis more effectively than the parent compound. N-methylthis compound achieves 97.7% intestinal region activation in Ascaris suum when combined with Cry5B, demonstrating synergistic anthelmintic effects .

Levamisole, a synthetic derivative of imidazothiazole, has garnered attention for its diverse biological activities, primarily as an antihelminthic agent and immunomodulator. Initially developed for veterinary use, it has been repurposed in various medical contexts, including oncology and dermatology. This article delves into the biological activity of this compound, highlighting its mechanisms, clinical applications, and associated case studies.

This compound exerts its effects through multiple pathways:

• Immunomodulation : this compound enhances immune responses by stimulating T-lymphocytes and macrophages. It increases the production of interleukin-2 (IL-2), interleukin-12 (IL-12), and interferon-gamma (IFN-γ), which are crucial for T helper cell activation. It also inhibits immunosuppressive factors, thereby restoring immune function in depressed states .
• Antiparasitic Action : The drug acts as an agonist at nicotinic acetylcholine receptors in nematodes, leading to paralysis and death of the parasites. This mechanism is pivotal in its use as an antihelminthic .
• Antiangiogenic Properties : Recent studies have indicated that this compound and its derivatives can inhibit angiogenesis. For instance, N-methylthis compound demonstrated significant antiangiogenic activity in vitro, suggesting potential applications in cancer therapy .

Clinical Applications

This compound has been utilized in various clinical settings:

• Dermatology : It is employed to treat skin conditions such as cutaneous leishmaniasis and warts due to its immunomodulatory properties .
• Oncology : this compound has been used as an adjuvant therapy in colorectal cancer, enhancing the efficacy of fluorouracil by modulating immune responses .
• Cocaine Adulteration : In recent years, this compound has been identified as a common adulterant in cocaine. Its presence is associated with severe adverse effects, including vasculitis and nephrotoxicity .

Case Study 1: this compound-Induced Vasculitis

A study reported cases of purpuric skin eruptions linked to this compound exposure among illicit drug users. The patients exhibited leukocytoclastic vasculitis upon skin biopsy, highlighting this compound's potential to induce severe dermatological reactions when used illicitly .

Case Study 2: Cognitive Impairments in Cocaine Users

Research indicates that cocaine users exposed to high levels of this compound demonstrate significant cognitive impairments. MRI studies revealed reduced cortical thickness in areas associated with executive function, suggesting that this compound may exacerbate cognitive deficits linked to cocaine use .

Research Findings

Recent investigations into this compound's biological activities have yielded significant insights:

Basic Research Questions

Q. What experimental models are most effective for studying Levamisole’s immunomodulatory mechanisms in preclinical research?

• Methodological Answer : Use in vitro assays (e.g., T-cell proliferation or cytokine profiling) combined with animal models (e.g., murine colitis or autoimmune disease models) to isolate this compound’s effects on immune cells. Validate findings via flow cytometry for lymphocyte subsets and ELISA for cytokine levels .

Q. How should researchers design dose-response studies to assess this compound’s efficacy in autoimmune or parasitic disease models?

• Methodological Answer : Employ a factorial design with varying doses (e.g., 2–10 mg/kg in rodents) and standardized outcome measures (e.g., parasite load reduction, histopathological scoring). Include positive controls (e.g., dexamethasone) and account for interspecies metabolic differences using allometric scaling .

Q. What are the key solubility parameters for this compound hydrochloride, and how do they influence formulation strategies?

• Methodological Answer : Determine solubility in polar solvents (e.g., water, DMSO) using gravimetric or UV-spectrophotometric methods at controlled temperatures (283–333 K). Apply thermodynamic models (e.g., NRTL or UNIQUAC) to predict solvent-drug interactions and optimize crystallization processes .

Advanced Research Questions

Q. How can researchers reconcile contradictory clinical data on this compound’s adjuvant efficacy in colorectal cancer?

• Methodological Answer : Perform a retrospective meta-analysis using Mantel-Haenszel methods to adjust for confounding variables (e.g., tumor staging, comorbidities). Stratify data by treatment duration (6 vs. 12 months) and analyze survival via Kaplan-Meier curves with log-rank tests .

Q. What statistical approaches are optimal for evaluating this compound’s interaction with other immunotherapies in combination trials?

• Methodological Answer : Use Cox proportional hazards models to assess time-to-event outcomes (e.g., recurrence-free survival). Incorporate interaction terms in regression models to quantify synergistic effects and adjust for multiplicity with Bonferroni corrections .

Q. How can thermodynamic properties inform this compound formulation stability under varying storage conditions?

• Methodological Answer : Conduct accelerated stability studies (40°C/75% RH) and correlate degradation kinetics with Hansen solubility parameters. Use differential scanning calorimetry (DSC) to detect polymorphic transitions and X-ray diffraction (PXRD) to confirm crystallinity .

Q. What ethical and practical considerations are critical when designing this compound trials in pediatric populations?

• Methodological Answer : Adhere to FINER criteria (Feasible, Interesting, Novel, Ethical, Relevant) for participant selection. Use age-adjusted dosing (e.g., 2.5 mg/kg) and monitor adverse events (e.g., leukopenia) via longitudinal CBC panels. Include placebo-controlled arms with DSMB oversight .

Q. Methodological Guidance

• Data Contradiction Analysis : Apply stratified subgroup analysis to isolate variables (e.g., smoking status in bronchogenic carcinoma trials) and report effect sizes with 95% confidence intervals .
• Experimental Reproducibility : Standardize immune assays using reference materials (e.g., WHO cytokine standards) and pre-register protocols on platforms like ClinicalTrials.gov .
• Thermodynamic Modeling : Validate solubility predictions with in silico tools (e.g., COSMO-RS) and cross-reference with experimental DSC/TGA data .